Loading clinical trials...
Loading clinical trials...
Randomized Phase II Trial: Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer
Conditions
Interventions
ATRA
PLACEBO
Locations
1
Mexico
National Institute of Cancerología
Mexico City, Mexico City, Mexico
Start Date
September 1, 2007
Primary Completion Date
December 1, 2008
Completion Date
November 1, 2009
Last Updated
January 13, 2010
NCT06487078
NCT06461338
NCT04738487
NCT04990479
NCT03950674
NCT03770299
Lead Sponsor
National Institute of Cancerología
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions